StemRIM (TSE:4599) EBITDA Margin % : 0.00% (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is StemRIM EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. StemRIM's EBITDA for the three months ended in Jan. 2024 was 円-538 Mil. StemRIM's Revenue for the three months ended in Jan. 2024 was 円0 Mil. Therefore, StemRIM's EBITDA margin for the quarter that ended in Jan. 2024 was 0.00%.

StemRIM EBITDA Margin % Historical Data

The historical data trend for StemRIM's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM EBITDA Margin % Chart

StemRIM Annual Data

Trend

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

EBITDA Margin %

Get a 7-Day Free Trial

-720.62

17.57

-38.02

-8,254.75

9.28

StemRIM Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EBITDA Margin %	Get a 7-Day Free Trial															-	76.51	-	-	-

Competitive Comparison of StemRIM's EBITDA Margin %

For the Biotechnology subindustry, StemRIM's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

StemRIM's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemRIM's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where StemRIM's EBITDA Margin % falls into.

StemRIM EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

StemRIM's EBITDA Margin % for the fiscal year that ended in Jul. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Jul. 2023 )	/	Revenue (A: Jul. 2023 )
	=	218.05	/	2350
	=	9.28 %

StemRIM's EBITDA Margin % for the quarter that ended in Jan. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jan. 2024 )	/	Revenue (Q: Jan. 2024 )
	=	-537.559	/	0
	=	%

StemRIM (TSE:4599) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

StemRIM EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of StemRIM's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

StemRIM (TSE:4599) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085

Website

https://www.stemrim.com

StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines